These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6407052)

  • 1. Psychological effects of dopamine beta-hydroxylase inhibition: a failure to replicate.
    Hartmann E; Oldfield M; Adelman S; Edelberg R
    Psychopharmacology (Berl); 1983; 79(4):352-6. PubMed ID: 6407052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The psychological effects of dopamine-beta-hydroxylase inhibition in normal subjects.
    Hartmann E; Keller-Teschke M
    Biol Psychiatry; 1979 Jun; 14(3):455-62. PubMed ID: 476231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 24-hour rhythm of human plasma noradrenaline and the effect of fusaric acid, a dopamine-beta-hydroxylase inhibitor.
    Kato T; Hashimoto Y; Nagatsu T; Shinoda T; Okada T; Takeuchi T; Umezawa H
    Neuropsychobiology; 1980; 6(2):61-5. PubMed ID: 7354907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biology of schizophrenia: Mental effects of dopamine-beta-hydroxylase inhibition in normal men.
    Hartmann E; Keller-Teschke M
    Lancet; 1977 Jan; 1(8001):37-8. PubMed ID: 63668
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of LH and prolactin release in the cycling rat following inhibition of dopamine-beta-hydroxylase.
    Voogt JL; Carr LA
    Brain Res; 1981 Mar; 209(2):411-9. PubMed ID: 6112041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification of cerebrovascular CO2 reactivity by inhibition of dopamine beta-hydroxylase.
    Oishi M; Gotoh F; Toyoda M; Seki T; Takeoka T; Takagi S; Niimi T
    Stroke; 1979; 10(4):407-11. PubMed ID: 41344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of dopamine-beta-hydroxylase inhibition on cerebral vasospasm in the cat.
    Battista AF; Flamm ES; Goldstein M; Freedman LS
    J Neurosurg; 1976 Feb; 44(2):168-72. PubMed ID: 1245859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interference of inhibitors of dopamine-beta-hydroxylase with uptake of monoamines by chromaffin granular membranes.
    Schlichter D; Da Prada M; Pletscher A
    Eur J Pharmacol; 1975 Nov; 34(1):223-7. PubMed ID: 187432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of dopamine-beta-hydroxylase inhibitors on blood pressure and cardiac norepinephrine levels in rats subjected to immobilization stress.
    Ishii Y; Mimura C; Homma M
    J Pharmacol Exp Ther; 1976 Sep; 198(3):589-95. PubMed ID: 988175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of fusaric acid (a dopamine beta-hydroxylase inhibitor) on phaeochromocytoma.
    Nagasaka A; Hara I; Imai Y; Uchikawa T; Yamauchi K; Suzuki S; Takatsuki K; Tomita A; Niinomi M; Nakagawa H
    Clin Endocrinol (Oxf); 1985 Apr; 22(4):437-44. PubMed ID: 3987067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible role of dopamine-beta-hydroxylase in the regulation of norepinephrine biosynthesis in rat brain.
    Wise CD; Belluzzi JD; Stein L
    Pharmacol Biochem Behav; 1977 Dec; 7(6):549-53. PubMed ID: 201940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological action of FD-008, a new dopamine-beta-hydroxylase inhibitor. III. Effects on endogenous biogenic amine levels in rats.
    Ishii Y; Homma M; Yoshikawa A; Umezawa H
    Arzneimittelforschung; 1975 Mar; 25(3):383-5. PubMed ID: 1174036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine beta-hydroxylase inhibition in a patient with Wilson's disease and manic symptoms.
    Pandey RS; Sreenivas KN; Patil NM; Swamy HS
    Am J Psychiatry; 1981 Dec; 138(12):1628-9. PubMed ID: 7304799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a dopamine beta-hydroxylase inhibitor on tissue catecholamine levels in spontaneously hypertensive rats subjected to immobilization-cold stress.
    Ishi Y; Homma M; Yoshikawa A
    Neuropharmacology; 1975 Feb; 14(2):155-7. PubMed ID: 1153081
    [No Abstract]   [Full Text] [Related]  

  • 15. The direct converstion of dopamine 3-O-sulfate to norepinephrine by dopamine-beta-hydroxylase.
    Buu NT; Kuchel O
    Life Sci; 1979 Feb; 24(9):783-9. PubMed ID: 571950
    [No Abstract]   [Full Text] [Related]  

  • 16. Blood pressure decreased by halobutylpicolinic acid, an inhibitor of dopamine beta-hydroxylase.
    Hidaka H; Takeya K
    Nature; 1972 Oct; 239(5371):334-5. PubMed ID: 12635227
    [No Abstract]   [Full Text] [Related]  

  • 17. Synthesis and characterization of immobilized dopamine beta-hydroxylase in membrane-bound and solubilized formats.
    Markoglou N; Wainer IW
    J Biochem Biophys Methods; 2001 Mar; 48(1):61-75. PubMed ID: 11282402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fusaric acid-induced elevation of homovanillic acid in the CSF as an index of brain noradrenaline synthesis.
    Elghozi JL; Laude D; Chaouloff F
    Eur J Pharmacol; 1985 Nov; 117(3):363-7. PubMed ID: 4076351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Schizophrenia: dopamine beta-hydroxylase activity and treatment response.
    Sternberg DE; VanKammen DP; Lerner P; Bunney WE
    Science; 1982 Jun; 216(4553):1423-5. PubMed ID: 6124036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Schizophrenia: a theory.
    Hartmann E
    Psychopharmacology (Berl); 1976 Aug; 49(1):1-15. PubMed ID: 183229
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.